what is happening with tirzepatide A recent post hoc analysis published in Obesity found vs. placebo was not associated increased risk of depression symptoms. Rates of suicidal ideation and behavior were low and similar to What happens if tirzepatide gets

Drop-off curve: 18 percent at three months, 31 percent at six months, 42 percent at nine months, 52 percent at year one

Last updated April 2026 Sources verified against the Zepbound FDA prescribing information, NEJM SURMOUNT-1 (Jastreboff et al., 2022), and Lillys Zepbound consumer page

What makes this approval especially interesting is convenience

GLP1 medications are peptide therapies that mimic (or enhance) gutbrain signaling involved in appetite, satiety, and glucose regulation

If you are comparing options, it may also help to look at Retatrutide vs Tirzepatide to see how these two peptides differ in their approach